Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Hemostemix Inc V.HEM

Alternate Symbol(s):  HMTXF

Hemostemix Inc. is a Canada-based clinical-stage biotechnology company. The Company’s principal business is to develop, manufacture and commercialize blood-derived stem cell therapies to treat various diseases. It is an autologous stem cell therapeutics company that holds 91 patents on the derivation of three stem cell lineages from the patient’s blood, including angiogenic cell precursors (ACP... see more

TSXV:HEM - Post Discussion

Hemostemix Inc > Share #
View:
Post by ENEMENEMYNEMO on Apr 25, 2022 9:54am

Share #

Does anyone know the fully diluted share number at this point, seems to be increasing dramatically?
Comment by WalterTheDawg on Apr 25, 2022 10:30am
Lots of warrants and options which would probably double the MC if exercised but the way I see it (dont quote me on that but it is a lot) most of those shares are 40 cents or higher so lets get that SP up first before we worry about dilution;) also all that money would go straight into the company's piggy bank to help fund a phase 3 and reduce the need for future financing so it's not ...more  
Comment by bayoubucks on Apr 26, 2022 3:53pm
Exercise of all warrants and options would increase shs approx 55 million pluse the latest debenture shs and wts.  This information is available in their financial statement filed on SEDAR.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities